Latest stories on ERNA
Ernexa Therapeutics Appoints Accomplished Biopharmaceutical Executive Robert J. Spiegel, M.D., FACP, to Board of Directors
GlobeNewswire59 · neutralgeneral
Ernexa Therapeutics Inc. (ERNAW) files 8-K
SEC 8-K50 · neutralgeneral
Ernexa Therapeutics Inc. (ERNAW) files 8-K
SEC 8-K50 · neutralgeneral
Ernexa reports preliminary results for ERNA-201, to focus resources on ERNA-101
The Fly59 · neutralproduct/pr
Ernexa Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Business Insider56 · neutralgeneral
Ernexa Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire56 · neutralgeneral
Ernexa Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference
GlobeNewswire56 · neutralgeneral
Ernexa Therapeutics CEO Corner Emphasizes How ERNA-101 Could Help Unlock the Next Generation of Combination Cancer Therapies
StockTitan73 · bullishproduct/pr
3 Most-Active Penny Stocks to Watch Today, 7/16/2026
TipRanks52 · neutralgeneral
Ernexa Therapeutics shares soar 30% after independent study validates cancer therapy (ERNA)
InvestorsHub73 · bullishgeneral
Eterna Therapeutics Holds 2026 Annual Stockholder Meeting
TipRanks50 · neutralgeneral
Eterna Therapeutics Updates Investor Presentation, Highlights Web Disclosures
TipRanks55 · neutralgeneral
Ernexa Therapeutics Inc. (ERNAW) files 8-K
SEC 8-K50 · neutralgeneral
Ernexa Therapeutics Inc. (ERNAW) files 8-K
SEC 8-K50 · neutralgeneral
Ernexa Therapeutics Inc. (ERNAW) files 8-K
SEC 8-K50 · neutralgeneral
ERNA,ERNAW: [SCHEDULE 13G/A] Ernexa Therapeutics Inc. Amended Passive Investment Disclosure
StockTitan SEC50 · neutralgeneral